Skip to main content
. 2019 Dec 26;49:233–241. doi: 10.1016/j.breast.2019.12.013

Fig. 5.

Fig. 5

Breast cancer specific survival curves in patients treated with and without chemotherapy by 21-gene RS categories (TAILORx cutoffs: intermediate-risk, A, high-risk, B; traditional RS cutoffs: intermediate-risk, C, high-risk, D).